Adverse events caused by nivolumab and ipilimumab can be sight-threatening

• Posted on: Feb 21 2019
• By: Saratoga Opthalmology
• Leave a response

This is the largest case series assessing ocular immune-related adverse events (IRAE) in patients treated with immunotherapy agents nivolumab and ipilimumab.
Source: AAO

Posted in: Uncategorized